2019 - Cancer Currents Blog
-
A physical rehabilitation program delivered by telephone improved function and reduced pain for people with advanced cancer, a clinical trial shows. The program also reduced the time patients spent in hospitals and long-term care facilities.
-
The investigational immunotherapy drug bintrafusp alfa (also called M7824), a bifunctional fusion protein, shrank the tumors of some patients with advanced HPV-related cancers, according to results from a phase 1 clinical trial.
-
In a study in young monkeys, researchers showed that a technique using stored testicular tissue led to successful conception. Researchers are hopeful the approach could eventually be a fertility preservation option for young boys being treated for cancer.
-
Findings from an NCI-funded study suggest a new vaccine approach may have the potential to prevent colorectal cancer in people with Lynch syndrome, an inherited condition that increases an individual's risk for developing certain types of cancer.
-
Doug Lowy, M.D., a long-time researcher and deputy director at NCI, addresses the cancer community as the institute's acting director, a position he previously held for more than 2 years.
-
Many women diagnosed with ovarian and breast cancer are not undergoing tests for inherited genetic mutations that can provide important information to help guide decisions about treatment and longer-term cancer screening, a new study has found.
-
Three research groups have found a potential way to kill cancer cells in pancreatic tumors by simultaneously blocking the activity of proteins that interact with KRAS proteins and disrupting an energy-creating process called autophagy.